On Wednesday, 8-3-22, the ISTH published comprehensive guidelines recommending for or against antithrombotic agents for Covid at defined levels of severity. Below are the task force guidelines and an editorial describing the research considerations behind guideline development.
Schulman S, Sholzberg M, Spyropoulos AC, et al. ISTH guidelines for antithrombotic treatment in COVID-19. JTH 2022, DOI: 10.1111/jth.15808
Spyropoulos AC, Connors JM, Douketis JD, et al. Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH. JTH 2022, DOI: 10.1111/jth.15809
No comments here.